Lv11
50 积分 2023-08-28 加入
Development of bifunctional anti-PD-L1 antibody MMAE conjugate with cytotoxicity and immunostimulation
4小时前
待确认
Development of bifunctional anti-PD-L1 antibody MMAE conjugate with cytotoxicity and immunostimulation
5小时前
已完结
Claudin 18.2 as a novel therapeutic target
3个月前
已完结
Claudin‐derived peptides are internalized via specific endocytosis pathways
3个月前
已完结
Interlaboratory variation in PD-L1 positivity in non-small cell lung cancer patients: a nationwide study
3个月前
已完结
Real-world prevalence of programmed death ligand 1 expression in locally advanced or metastatic non–small-cell lung cancer: The global, multicenter EXPRESS study
4个月前
已完结
CMG901, a Claudin18.2-specific antibody-drug conjugate, for the treatment of solid tumors
4个月前
已完结
Clinicopathological analysis of claudin 18.2 focusing on intratumoral heterogeneity and survival in patients with metastatic or unresectable gastric cancer
9个月前
已完结
PD-L1 Expression and Intratumoral Heterogeneity Across Breast Cancer Subtypes and Stages
10个月前
已完结
Pembrolizumab plus eribulin in hormone-receptor–positive, HER2-negative, locally recurrent or metastatic breast cancer (KELLY): An open-label, multicentre, single-arm, phase Ⅱ trial
11个月前
已完结
皖公网安备34019202002308
